Last $73.88 USD
Change Today +0.14 / 0.19%
Volume 4.6M
ITMN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

W. Scott Harkonen M.D.

Former Director, InterMune, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 board members in 1 different organizations across 5 different industries.

See Board Relationships
62--

Background*

Dr. W. Scott Harkonen, M.D. served as the Chief Executive Officer and President of CoMentis, Inc. Dr. Harkonen has over 20 years of experience in the biopharmaceutical industry. He served as Chief Executive Officer of CoTherix Inc., since October 2003 and as its Chairman from April 2001 to July 2004. He was the Founder of InterMune Inc. and served as its Chairman since January 2000, Chief Executive Officer and President from 1999 to 2003 and also served as its Consultant. ...

Read Full Background

Corporate Headquarters*

3280 Bayshore Boulevard
Brisbane, California 94005

United States

Phone: 415-466-2200
Fax: 415-466-2300

Board Members Memberships*

Former Director
Former Director
Director
Former Chief Executive Officer, President and Director
1998-N/A
Former Director
2001-2004
Former Chairman and Chief Executive Officer

Education*

BA
University of Minnesota
MD
University of Minnesota
Master's Degree
Haas School of Business
MBA
Haas School of Business

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ITMN:US $73.88 USD +0.14

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Harvey J. Berger M.D.Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Ariad Pharmaceuticals Inc.
$749.8K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$548.8K
Clay B. Siegall Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Seattle Genetics Inc.
$724.4K
Rajesh C. Shrotriya M.D.Chairman, Chief Executive Officer, Chairman of Product Acquisition Committee and Chairman of Placement Committee
Spectrum Pharmaceuticals, Inc.
$1.8M
David T. Hung M.D.Founder, Chief Executive Officer, President and Executive Director
Medivation, Inc.
$750.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTERMUNE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.